The Chief Executive Officer of DRAP held a productive meeting today with Dr. Zakiya, Senior Manager, Public Policy and Regulatory Affairs (EMEA), USP, and Dr. Geoff Tsen, General Manager and Vice President, Regional Program Operations, USP China. The discussion reflected mutual commitment to enhancing regulatory practices and supporting Pakistan’s pharmaceutical industry.
Officials from USP underscored the value of a close partnership with DRAP to build institutional capacity and improve regulatory oversight. Emphasis was placed on collaborative approaches that enable stronger regulatory systems and better alignment with international benchmarks, reinforcing the role of the DRAP USP relationship in raising local standards.
Participants explored practical avenues of cooperation, including technical assistance, targeted capacity building, and regulatory system strengthening. Alignment with international best practices and knowledge exchange were highlighted as priorities that can help Pakistan’s therapeutic goods sector meet evolving global requirements.
The engagement signals a shared vision for sustainable development initiatives that support industry growth, ensure safer medicines, and promote public health. Strengthening ties between DRAP and USP aims to translate technical collaboration into more robust regulation and healthier communities across Pakistan.
